Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Public ClinicalTrials.gov record NCT06700343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics, and Clinical Effects Between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects With Relapsing-remitting Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Main objectives of the study are to demonstrate pharmacokinetic (PK) similarity between ABP 692 and ocrelizumab (US), as well as between ABP 692 and ocrelizumab (EU).
Study identification
- NCT ID
- NCT06700343
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 152 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2025
- Primary completion
- Apr 18, 2027
- Completion
- Oct 3, 2027
- Last update posted
- Jul 26, 2026
2025 – 2027
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama | Mobile | Alabama | 36617 | — |
| Clinical Endpoints, LLC | Scottsdale | Arizona | 85258 | — |
| Profound Research - Neurology Center of Southern California | Carlsbad | California | 92011 | — |
| Mountain Neurological Research Center | Basalt | Colorado | 81621 | — |
| Advanced Neurosciences Research, Llc | Fort Collins | Colorado | 80528 | — |
| Hasbani Neurology | New Haven | Connecticut | 06511 | — |
| Neurology Offices of South Florida | Boca Raton | Florida | 33428 | — |
| Aqualane Clinical Research | Naples | Florida | 34105 | — |
| Emerald Coast Neurology/Synergy Clinical Research | Pensacola | Florida | 32504 | — |
| Knight Neurology | Rockledge | Florida | 32955 | — |
| Premiere Research Institute Palm Beach | West Palm Beach | Florida | 33407 | — |
| Hawaii Pacific Neuroscience | Honolulu | Hawaii | 96817 | — |
| Rush University Medical Center, Rush University Cancer Center | Chicago | Illinois | 60612-3841 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Henry Ford Health | Detroit | Michigan | 48202 | — |
| Michigan Institute For Neurological Disorders (Glendale Neurological Associates) - Farmington Hills | Farmington | Michigan | 48334-2979 | — |
| JFK Medical Center | Edison | New Jersey | 08820 | — |
| Hackensack Meridian Health | Paramus | New Jersey | 07652 | — |
| University of NM/Mind Imaging center | Albuquerque | New Mexico | 87131 | — |
| Triad Neurological Associates | Winston-Salem | North Carolina | 27103 | — |
| Singlepoint Healthcare Opco, LLC | Columbus | Ohio | 43235 | — |
| NDx Clinical Research, Inc | Dayton | Ohio | 45459 | — |
| Premier Neurology, PC | Greenville | South Carolina | 29650 | — |
| Hope Neurology | Knoxville | Tennessee | 37922 | — |
| Vanderbilt University Medical Center (VUMC) | Nashville | Tennessee | 37215 | — |
| Lone Star Neurology | Frisco | Texas | 75035 | — |
| Froedtert Hospital-Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06700343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06700343 live on ClinicalTrials.gov.